Topiramate Capsule, Coated Pellets
Product Images NDC 68382-005

6 FDA label images from Zydus Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68382-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Product Formula For Topiramate (69df5f84 1db1 4eb2 Ae32 462137a4d812 01)

Structured Product Formula For Topiramate (69df5f84 1db1 4eb2 Ae32 462137a4d812 01)
Chemical structure of topiramate shown as a molecular diagram with atoms and bonds illustrating its unique arrangement including oxygen, carbon, sulfur, nitrogen, and hydrogen atoms.*
FDA Label Image

Structured Product Formula For Topiramate (69df5f84 1db1 4eb2 Ae32 462137a4d812 02)

Structured Product Formula For Topiramate (69df5f84 1db1 4eb2 Ae32 462137a4d812 02)
A line graph showing cumulative rates for time to first seizure over 500 days for topiramate at 50 mg/day and 400 mg/day. The graph compares two groups, with 234 and 236 participants respectively, using solid and dashed lines for the lower and higher doses.*
FDA Label Image

Topiramate Tablets Usp (69df5f84 1db1 4eb2 Ae32 462137a4d812 03)

Topiramate Tablets Usp (69df5f84 1db1 4eb2 Ae32 462137a4d812 03)
A bar chart depicting the change from baseline to double-blind phase in average monthly migraine period rate for placebo and topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day. The chart compares results from two studies, labeled Study 11 and Study 12, showing a decreasing trend in migraine rates with increasing topiramate doses. Statistical significance is indicated for higher doses with p-values less than 0.010 and 0.001.*
FDA Label Image

Topiramate Tablet-sl-25mg (69df5f84 1db1 4eb2 Ae32 462137a4d812 04)

Topiramate Tablet-sl-25mg (69df5f84 1db1 4eb2 Ae32 462137a4d812 04)
Topiramate Capsules, USP 15 mg coated pellets oral medication label. The label shows a quantity of 60 capsules and is labeled Rx only. Manufacturer is Zydus Pharmaceuticals USA Inc., with distribution by Zydus Lifesciences Ltd., India. Storage instructions and a child-resistant package notice are included, along with a reminder for pharmacists to provide the medication guide separately to patients.*
FDA Label Image

Topiramate Tablet-sl-25mg-60c (69df5f84 1db1 4eb2 Ae32 462137a4d812 05)

Topiramate Tablet-sl-25mg-60c (69df5f84 1db1 4eb2 Ae32 462137a4d812 05)
Topiramate Capsules, USP 25 mg oral capsules label by Zydus Pharmaceuticals USA Inc. The label shows a package of 60 capsules with the NDC 68382-005-14. Important storage and safety information is included, noting the product is child-resistant and instructions to keep out of reach of children.*
FDA Label Image

Topiramate Tablet-sl-100mg-60c (69df5f84 1db1 4eb2 Ae32 462137a4d812 06)

Topiramate Tablet-sl-100mg-60c (69df5f84 1db1 4eb2 Ae32 462137a4d812 06)
Topiramate Capsules, USP 50 mg oral capsules label by Zydus Pharmaceuticals USA Inc. The label shows a quantity of 60 capsules per container, with instructions emphasizing child-resistant packaging, storage at controlled room temperature, and dispensing with a medication guide. The label includes the NDC 68382-498-14 and is marked for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.